Cupid Limited Highlights Strong FY26 Performance & Expanding Growth Platform at 33rd AGM

Mr. Aditya Kumar Halwasiya outlines FY27 guidance of ₹725–750 crore revenue and ₹210–225 crore net profit; highlights consumer growth, Palava capacity expansion, global healthcare opportunities and new international initiatives Mumbai…

TB Alliance ZeNix trial Show Effectiveness of BPaL Regimen for Highly Drug-Resistant TB

ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure to the drug linezolid India has the leading number of TB cases…